Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea (ERA)

Associacao Fundo de Incentivo a Psicofarmcologia

Status: Unknown

Conditions: Obesity; Obstructive Sleep Apnea

Study type: Observational

Funder types: Other

Identifiers

NCT00768625

ERA

Details and patient eligibility

About

The purpose of this study is:

1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI<25)
2. To analyze the CPAP treatment over the clinical evolution of OSA patients
3. To determine if OSA is a independent predictor of cardiovascular risk

Full description

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We hypothesized that the cardiovascular consequences of OSA are due to obesity.

Enrollment: 2,000 estimated patients

Sex: All

Ages: 30 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)

Exclusion criteria

• Body mass index higher than 40